Oxionbio

Oxion Bio is a biotechnology company focused on the discovery and development of next-generation small molecule therapeutics targeting ion channels. The company leverages a proprietary drug discovery platform that combines advanced electrophysiology with high-throughput screening to identify highly selective modulators of challenging ion channel targets. Their primary therapeutic focus includes addressing unmet needs in chronic pain, inflammatory conditions, and various neurological disorders. By targeting specific ion channel subtypes, Oxion Bio aims to develop treatments with improved efficacy and reduced side-effect profiles compared to current standards of care. The company is currently in the pre-clinical stage, advancing its lead programs toward candidate selection.